Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06608940
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-20
Brief Title:
BC3402 w Tremelimumab Durvalumab STRIDE in Hepatocellular Carcinoma
Sponsor:
Organization:
None